
Evaluating the health economic impact of cefepime/enmetazobactam in complicated urinary tract infections in the German setting: a cost analysis from payer perspective
Johanna Röder, Sebastian M Wingen-Heimann, Danila Seidel, Ann-Cathrine Froitzheim, Melina S Kurte, Oliver Witzke, Maria J G T Vehreschild, Oliver A Cornely, Florian Kron